Showing results (1631-1640 of 2,322) with videos related to

Sort By:
Pageof 233
The EMBO Journal|October 1, 2004
Structural insights into the regulation of PDK1 by phosphoinositides and inositol phosphatesDavid Komander, Alison Fairservice, Maria Deak, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 17, 2015
Casein kinase II promotes target silencing by miRISC through direct phosphorylation of the DEAD-box RNA helicase CGH-1Amelia F Alessi, Vishal Khivansara, Ting Han, et al.
Frontiers in Oncology|November 30, 2018
BRAF V600E Inhibitor (Vemurafenib) for BRAF V600E Mutated Low Grade GliomasFrancesca Del Bufalo, Giulia Ceglie, Antonella Cacchione, et al.
Expert Review of Anticancer Therapy|April 9, 2013
Treatment of hepatocellular carcinoma: present and futureChiara Genco, Giuseppe Cabibbo, Marcello Maida, et al.
Journal of Perinatal Medicine|November 18, 2022
Healthcare of pregnant women with diabetes during the COVID-19 pandemic: a Southern Brazilian cross-sectional panel dataRoberta de Pádua Borges, Georgia Oliveira Avila, Amanda Cunha Ritter, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|February 8, 2023
Reference intervals for glycated albumin during physiological pregnancy of Europid women: Evidences from a prospective observational studyRenata Paleari, Matteo Vidali, Ferruccio Ceriotti, et al.
JMIR AI|July 3, 2025
Comparative Performance of Medical Students, ChatGPT-3.5 and ChatGPT-4.0 in Answering Questions From a Brazilian National Medical Exam: Cross-Sectional Questionnaire StudyMateus Rodrigues Alessi, Heitor Augusto Gomes, Gabriel Oliveira, et al.
Archives of Endocrinology and Metabolism|October 18, 2024
Clinical features most frequently present in patients with concomitant diabetic kidney disease and diabetic retinopathyMateus Augusto Dos Reis, Janine Alessi, Josiane Schneiders, et al.
Thrombosis Journal|August 30, 2008
Use of rosiglitazone before and after vascular injury in hypercholesterolemic rabbits: Assessment of neointimal formationAlexandre Alessi, Olímpio Ribeiro França Neto, Paulo Roberto Slud Brofman, et al.
The Biochemical Journal|September 2, 2014
Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinaseRuzica Bago, Nazma Malik, Michael J Munson, et al.
Pageof 233